Red Lake Nation News - Babaamaajimowinan (Telling of news in different places)

Medical device's price stirs Washington: Cost increase of EpiPen 'alarming,' 'unjustified,' Klobuchar says


Since 5-year-old Matthew Nicholls was diagnosed with a tree-nut allergy at age 2, his mom and dad have spent more than $1,000 on EpiPens that have never been used — but have to be kept on hand in case Matthew has a potentially life-threatening allergic reaction.

“I would so much rather be putting the money into a college fund!” wrote Matthew’s mother, Katie Nicholls, in an email from the home in Lafayette, La., to which the family moved from Duluth last year.

The drug company Mylan Pharmaceuticals has a virtual lock on sales of the device, which is designed to safely and simply inject an exact amount of the drug epinephrine, the only first-line treatment for the allergic reaction anaphylaxis. But Mylan has come under fire for what Sen. Amy Klobuchar, D-Minn., calls an “alarming” and “unjustified” price increase.


Reader Comments(0)


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021

Rendered 12/05/2021 22:22